Company page
Exagen Inc.
Exagen Inc. is a public company traded under the ticker XGN in the American market. The company has a market capitalization of approximately $109.7 million. Exagen focuses on developing and commercializing innovative diagnostic tests for autoimmune diseases.
- Ticker
- XGN:NASDAQ
- Asset type
- Stock
- Market cap
- $109.7M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD